A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity.
Experimental and clinical evidence has pinpointed a critical role for matrix metalloproteinase-2 (MMP-2) in ischemic ventricular remodeling and systolic heart failure. Prior studies have demonstrated that transgenic expression of the full-length, 68 kDa, secreted form of MMP-2 induces severe systoli...
Main Authors: | David H Lovett, Rajeev Mahimkar, Robert L Raffai, Leslie Cape, Elena Maklashina, Gary Cecchini, Joel S Karliner |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3317925?pdf=render |
Similar Items
-
N-terminal truncated intracellular matrix metalloproteinase-2 induces cardiomyocyte hypertrophy, inflammation and systolic heart failure.
by: David H Lovett, et al.
Published: (2013-01-01) -
A N-terminal Truncated Intracellular Isoform of Matrix Metalloproteinase-2 Impairs Contractility of Mouse Myocardium
by: David H Lovett, et al.
Published: (2014-09-01) -
Two Distinct Isoforms of Matrix Metalloproteinase-2 Are Associated with Human Delayed Kidney Graft Function.
by: Shaynah Wanga, et al.
Published: (2015-01-01) -
Enhanced cardiac expression of two isoforms of matrix metalloproteinase-2 in experimental diabetes mellitus.
by: Hye Won Lee, et al.
Published: (2019-01-01) -
Enhanced expression of two discrete isoforms of matrix metalloproteinase-2 in experimental and human diabetic nephropathy.
by: Sang Soo Kim, et al.
Published: (2017-01-01)